Biomea Fusion, Inc. - Common Stock (NQ:BMEA)

1.331 +0.011 (+0.86%)

Delayed Quote Updated: 12:23 PM EDT, Oct 8, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biomea Fusion, Inc. - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Rosen Law Firm Encourages Biomea Fusion, Inc. Investors With Losses in Excess of $100K to Inquire About Securities Class Action Investigation – BMEA

June 13, 2024

From The Rosen Law Firm, P.A.

Via Business Wire

Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

June 13, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

June 13, 2024

Via Benzinga

This Cleveland-Cliffs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

June 11, 2024

Via Benzinga

Crude Oil Edges Lower; Asensus Surgical Shares Jump ↗

June 07, 2024

Via Benzinga

Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 07, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 07, 2024

Via Benzinga

Gold Falls Sharply; Geron Shares Spike Higher ↗

June 07, 2024

Via Benzinga

Why Biomea Fusion (BMEA) Stock Is Down 60% ↗

June 07, 2024

Biomea Fusion shares are trading lower by 62.7% during Friday's session. The company received notice from the FDA that Its trials of BMF-219 have been placed on clinical hold.

Via Benzinga

US Stocks Lower; Nonfarm Payrolls Increase More Than Expected ↗

June 07, 2024

Via Benzinga

Biomea Fusion Crashes 65% After FDA Puts Diabetes Treatment Studies On Hold ↗

June 07, 2024

The FDA cited concerns of liver toxicity, but the company says its drug has been generally well-tolerated.

Via Investor's Business Daily

Why Is Virax Biolabs (VRAX) Stock Down 15% Today? ↗

June 07, 2024

Virax Biolabs stock is down on Friday as shares of VRAX come off of a massive rally yesterday that didn't come with any news.

Via InvestorPlace

Vail Resorts Posts Downbeat Q3 Results, Joins Concrete Pumping, DocuSign And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 07, 2024

Via Benzinga

Why Is Biomea Fusion (BMEA) Stock Down 63% Today? ↗

June 07, 2024

Biomea Fusion stock is falling on Friday after investors learned of the FDA placing a clinical hold on its Phase I/II clinical trials.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 07, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 07, 2024

Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!

Via InvestorPlace

This Pharma Stock Dropped 60% Premarket As FDA Halted Diabetes Drug Trials ↗

June 07, 2024

Elevated liver enzyme levels were noted, although most adverse events were mild to moderate, with no severe reactions reported.

Via Benzinga

Ride the Gamma Wave: 3 Stocks on the Verge of a Short Squeeze ↗

June 07, 2024

Though short squeezes are never guaranteed, these three potential short squeeze stocks could provide generous returns if bought right.

Via InvestorPlace

Why Braze Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket ↗

June 07, 2024

Via Benzinga

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Biomea Fusion, Inc. and Encourages Investors with Losses to Contact the Firm

June 06, 2024

From Schall Law

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 06, 2024

Via Benzinga

Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold

June 06, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Short Squeeze Specialists: 3 Stocks With the Expertise to Defy Bearish Expectations ↗

June 06, 2024

Sometimes the bears can push their luck too much, leading to a reverse response. That’s the incentive behind these short squeeze stocks.

Via InvestorPlace

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

June 03, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion Announces Completion of Enrollment of First 3 Arms in Phase 2 Expansion Cohorts of COVALENT-111 Study for BMF-219 in Type 2 Diabetes

May 30, 2024

BMF-219 is an investigational novel covalent menin inhibitor developed to regenerate insulin-producing beta cells

From Biomea Fusion, Inc.

Via GlobeNewswire

BMEA Stock Earnings: Biomea Fusion Misses EPS for Q1 2024 ↗

May 02, 2024

BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights

May 02, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

May 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

April 01, 2024

From Biomea Fusion, Inc.

Via GlobeNewswire

BMEA Stock Earnings: Biomea Fusion Misses EPS for Q4 2023 ↗

April 01, 2024

BMEA stock results show that Biomea Fusion missed analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.